Updates and news related to prostate cancer:
Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor
View this presentation by Wassim Abida, MD, PhD, and colleagues at the 2021 ASCO GU Cancers Symposium.
The trial also demonstrated a safety profile that was consistent with previous research investigating this combination treatment regimen.
Healthy Lifestyle May Reduce Likelihood of Lethal Prostate Cancer Among Those With High Genetic Risk
In this study, a healthy lifestyle did not attenuate genetic risk of overall prostate cancer but did attenuate the genetic risk of lethal disease in men at highest genetic risk.
Androgen Annihilation Strategy Prolongs Radiographic Progression-Free Survival in Metastatic Castration Resistant Prostate Cancer
An article from Us TOO International's HOT SHEET, April 2021
How do we know what’s accurate when some cancer myths can sound perfectly logical?
Learn more about common biopsy techniques, and why they are not likely to cause cancer to spread.
(CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer.
Intensive Neoadjuvant Hormonal Therapy
Ashley Ross is joined by Daniel Spratt presenting a European Association of Urology publication on A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.